AXL and breast cancer: To elucidate the clinical significance of AXL expression in breast cancer patients, we analyzed a cohort of 73 breast cancer patients by Kaplan-Meier survival analysis and observed that high levels of AXL expression (n = 36) were significantly correlated with poor survival outcomes compared to those with low levels of AXL (n = 37) (Figure 1A).